Skip Nav Destination
Article navigation
February 1997
Conference Abstract|
February 01 1997
Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection
MR Thursz;
MR Thursz
1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY
Search for other works by this author on:
D Kwiatkowski;
D Kwiatkowski
1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY
Search for other works by this author on:
C Allsopp;
C Allsopp
1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY
Search for other works by this author on:
B Greenwood AVS Hill;
B Greenwood AVS Hill
1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY
Search for other works by this author on:
HC Thomas
HC Thomas
1Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY
Search for other works by this author on:
Clin Sci (Lond) (1997) 92 (s36): 6P.
Citation
MR Thursz, D Kwiatkowski, C Allsopp, B Greenwood AVS Hill, HC Thomas; Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection. Clin Sci (Lond) 1 February 1997; 92 (s36): 6P. doi: https://doi.org/10.1042/cs092006Pa
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
2
Views
0
Citations